• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
PoliticsU.S. Politics

2020 Election Update: Sanders Would Meet Putin; Harris Threatens Drug Maker Probe; Biden Won’t Be ‘Third Term of Obama’

By
Laura Litvan
Laura Litvan
,
Jennifer Epstein
Jennifer Epstein
,
Sahil Kapur
Sahil Kapur
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Laura Litvan
Laura Litvan
,
Jennifer Epstein
Jennifer Epstein
,
Sahil Kapur
Sahil Kapur
and
Bloomberg
Bloomberg
Down Arrow Button Icon
July 16, 2019, 11:32 AM ET

Bernie Sanders Says He Would Meet With Dictators

Bernie Sanders said that as president he would sit down with authoritarian leaders like North Korea’s Kim Jong Un or Russia’s Vladimir Putin even though he remains critical of President Donald Trump’s “respect and affection for” dictators around the world.

“Should we sit down and negotiate with them? Absolutely,” the Vermont senator and Democratic White House contender said at a Washington Post Live news event Tuesday. “Should we praise them as a great leader? I don’t think so.”

Sanders also said that he would directly engage with leaders of Iran to try to improve strained relations and quell the risks of conflict that have been escalating under Trump. He said he would convene a broader meeting between the U.S., Iran, Saudi Arabia and other Middle Eastern nations to try to reduce tensions in the region.

“I think there is an opportunity to sit down with them, explain to them our concerns about their support for this or that terrorist group, their missile program,” Sanders said in the wide-ranging interview. “But also to tell Saudi Arabia and Iran that we are sick and tired of losing young men and women in the war on terror and spending trillions of dollars.”

Meanwhile, Sanders said he probably would not move the U.S. Embassy back to Tel Aviv from Jerusalem if he’s elected, although he said that could be a factor in peace talks among the U.S., Israel and Palestinians. Trump in late 2017 announced U.S. Recognition of Jerusalem as Israel’s capital, even though it is disputed territory.

Joe Biden Says He Won’t Be ‘Third Term of Obama’

Joe Biden’s presidency wouldn’t just be a continuation of Barack Obama’s two terms, the former vice president contended in an interview airing Tuesday.
“This is not a third term of Obama,” he told MSNBC’s Mika Brzezinski in an interview conducted Monday in Iowa when she asked about his relationship with the former president.

“The world’s changed. It’s different. We have the same value set, he and I,” Biden said. “It’s a different world. The same things don’t apply.”

The Democratic front-runner frequently invokes Obama on the campaign trail and has offered policy positions that align closely with the Obama administration’s work. He unveiled a plan Monday to defend and build on the Affordable Care Act at a time when other Democratic presidential hopefuls are looking past the signature Obama achievement on health care and advocating for Medicare for All. And he even fell into a trap Monday that Obama set on health care a decade ago, promising that under his proposal, “if you like your health care plan, your employer based plan, you can keep it.”

Despite their close ties — which Biden noted include friendships between his granddaughters and Malia and Sasha Obama — Obama has not endorsed Biden, which he claimed in the interview was “because I have asked him not to do that — I don’t want to put him in that spot and I want to earn this on my own.” Obama has said that he will stay out of the Democratic primary until there is a nominee to avoid influencing the race.

Even without an endorsement, Biden wants voters to know that the ties run deep. “We’re friends. You know, it’s family,” he said.

Kamala Harris Threatens to Probe Drug Makers

A centerpiece of Kamala Harris’s new plan to tackle rising prescription drug prices is a threat to launch an investigation into drug companies that are “price-gouging patients.”

The Democratic contender says she’d do that by executive action if Congress doesn’t pass her plan to lower drug costs in her first 100 days. She says she’d demand that the bad actors lower their prices, and if they refuse, use regulatory powers to import cheaper alternatives and license some patents to low-cost competitors under the Bayh-Dole Act.

More must-read stories from Coins2Day:

—What to expect from the second Democratic debate

—Who wins and loses as White House withdraws drug rebate plan

—A new holding center for migrant children is open in Texas

—Fed Chairman Powell: If Trump asks me to leave, I won’t

—Tom Steyer mastered markets and now he wants to topple Trump

Get up to speed on your morning commute with Coins2Day’s CEO Daily newsletter.

About the Authors
By Laura Litvan
See full bioRight Arrow Button Icon
By Jennifer Epstein
See full bioRight Arrow Button Icon
By Sahil Kapur
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.